Vorhandelsmarkt: 6.29

Mannkind Corp (MNKD)

Mannkind Corp Aktie (MNKD) Neueste Nachrichten

Mannkind Corp (MNKD)

Mannkind Corp Aktie (MNKD) Neueste Nachrichten

MannKind's SWOT analysis: inhaled therapeutics firm's stock shows promise amid challenges - Investing.com

More Adults With Type 1 Diabetes Achieved A1C Goal (<7%) After Switching From Multiple Daily Insulin Injections or Automated Pumps to Inhaled Insulin (Afrezza®) - GlobeNewswire Inc.

MannKind Co. (NASDAQ:MNKD) Shares Bought by Dark Forest Capital Management LP - MarketBeat

Mannkind Corp (MNKD)’s results reveal risk - US Post News

The Attractiveness of Investing In Mind Medicine Inc (MNMD) is Growing - Knox Daily

A new trading data show Mannkind Corp (MNKD) is showing positive returns. - SETE News

MNKD stock rated an Outperform by Leerink Partners - Knox Daily

Closing Figures: Mind Medicine Inc (MNMD)’s Negative Finish at 5.87, Down -1.68 - The Dwinnex

Manba Finance IPO Sees Stellar 73.18 Times Subscription on Second Day - Devdiscourse

Manba Finance IPO subscribed 73.18 times on Day 2 amid heavy demand from institutional investors - NewsDrum

Latest News - LatestLY

Mind Medicine Inc (MNMD) produces promising results - US Post News

Stock market update: Nifty Pharma index advances 0.23% - The Economic Times

Manba Finance IPO continues to attract great interest, subscribed 73 times on day 2 - Moneycontrol

Manba Finance IPO subscribed 56 times so far on Day 2 - Indiainfoline

Manba Finance IPO Day 2: Issue subscribed 41.11 times so far, check key dates and more - Upstox

Manaba Finance IPO Day 2: Check latest subscription, expected listing gains - India Today

Mankind Pharma To Raise Rs 7,000-Crore Debt For Bharat Serums Acquisition - NDTV Profit

Stock to buy today: Mankind Pharma (₹2,651.30): BUY - BusinessLine

Trade Spotlight: How should you trade Siemens, Mankind Pharma, Kotak Bank, DLF, Indegene and others on... - Moneycontrol

Avoro Capital Advisors LLC Reduces Stock Position in MannKind Co. (NASDAQ:MNKD) - MarketBeat

Manba Finance Limited IPO Subscribed 23.67 Times on Day 1 of Bidding, Sale To Conclude on September 25; - LatestLY

Manba Finance IPO subscribed 23.67 times on Day 1 - NewsDrum

Mankind Pharma announces ₹10,000 crore fundraise | Tap to know more | Inshorts - Inshorts

Pharma stock jumps 4% after company announces ₹ 10,000 Cr fundraise - Trade Brains

Mankind Pharma Announces NCD Fundraising Initiative - Indiainfoline

Mankind Pharma Ltd soars 3.76% - Business Standard

Mankind Pharma up 4% as board approves raising Rs 10,000-cr via NCDs, CPs - Business Standard

Mankind Pharma plans to repay debt taken for BSV acquisition within three years - CNBCTV18

Mankind Pharma Shares Hit Record High After Company Announces ₹10,000 Crore Fund Raising - Free Press Journal

Mankind Pharma Shares Hit Life High After Board Nod To Rs 10,000 Crore Fundraise - NDTV Profit

Mankind Pharma jumps to record high; gains 9% in two days after Investec's 'buy' tag - Moneycontrol

Fundamentally strong pharma stocks to buy now for an upside of 30% - Trade Brains

Mankind Pharma shares surge over 2% after board approves raising Rs 10,000 crore - Business Upturn

Manba Finance Raises ₹45.25 Crore from Anchor Investors Ahead of IPO - Indiainfoline

Stocks in focus on 23rd September: HDFC Bank, Mankind Pharma, BHEL, Tata Steel and more - Business Upturn

MannKind Co. (NASDAQ:MNKD) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Mankind Pharma board OKs to raise Rs 10,000 cr - Business Standard

MannKind Corporation (MNKD): Short Seller Sentiment is Bearish - Insider Monkey

MannKind Corporation (MNKD): Short Seller Sentiment is Bearish - Yahoo Finance

14 Worst 52-Week High Stocks to Buy According to Short Sellers - Insider Monkey

MNKD Shares Experience Surge in Value - Knox Daily

Mankind Pharma board approves raising Rs 10,000 crore through NCDs - The Economic Times

Riding the Waves: A Guide to Investing in MNKD Stock - The InvestChronicle

Mankind Pharma to raise up to ₹10,000 crore through NCDs - CNBCTV18

Mankind Pharma to raise funds up to Rs 10k crore via debt instruments - Business Standard

Broker’s call: Mankind Pharma (Buy) - BusinessLine

Mankind Pharma board gives nod to Rs 10,000 crore fundraise via bonds - MSN

Mankind Pharma board approves up to Rs 10,000-crore fund raise via NCDs, CPs - Moneycontrol

Mankind Pharma to raise up to Rs 10,000 crore through bonds - Zee Business

Mankind Pharma Board approves raising Rs 10,000 crore via NCDs and CPs - Business Upturn

India's Mankind Pharma hits record high after Investec sets Street-high price target - XM

Mankind Pharma shares surge to a record high after Investec projects 35% upside - CNBCTV18

Mankind up 7% ahead of board meet for fund raising; m-cap tops Rs 1 trn - Business Standard

Sensex Today Trades Higher | Nifty Above 25,450 | IIFL Finance Rallies 10%, Mankind Pharma Jumps 4% - Equitymaster

Mankind Pharma shares zoom 7% to new record high after Investec initiates coverage with 'buy' rating, sees 36% upside | Stock Market News - Mint

Mankind Pharma shares surge 5% after Investec initiates ‘Buy’ call - Business Upturn

Mankind Pharma stock rises 4% as Investec initiates with 'buy' - Moneycontrol

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Acquired by Bank of New York Mellon Corp - MarketBeat

Mannkind Corp (MNKD) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

MannKind advances phase 3 NTM lung disease study - Investing.com

Mankind Pharma board to consider fund raising on Sep 20 - Business Standard

Mankind Pharma to consider fund raise on September 20 - Moneycontrol

Stocks To Watch: Infosys, Mankind Pharma, Ceigall India, REC, Torrent Power, ONGC And More - NDTV Profit

Mankind Pharma board to meet this week to consider fund raising - The Economic Times

Mankind Pharma Share Price Could Jump as Board Considering Fund Raising for Expansion - TopNews India

Mannkind Corp (MNKD) gets rating Resumed from Leerink Partners - Knox Daily

MannKind (NASDAQ:MNKD) Sets New 52-Week High at $6.50 - MarketBeat

Take off with Mannkind Corp (MNKD): Get ready for trading - SETE News

Insider’s View: Deciphering Mannkind Corp (MNKD)’s Financial Health Through Ratios - The Dwinnex

MannKind Corporation (MNKD): Short Seller Sentiment is Bearish on This Stock - Insider Monkey

MannKind Co. (NASDAQ:MNKD) Shares Purchased by Bank of New York Mellon Corp - MarketBeat

MNKD Stock: Exploring Mannkind Corp’s Growth - The InvestChronicle

10 Worst Cancer Stocks To Buy Now According to Short Sellers - Insider Monkey

Ähnlich wie MNKD